Trials / Completed
CompletedNCT06472778
A Real-world Study in Participants With Smoldering Multiple Myeloma
Smoldering Pathway Assessment Real-World Knowledge (SPARK) Study-Retrospective Observational, Non-interventional Chart Review Study in Smoldering Multiple Myeloma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 431 (actual)
- Sponsor
- Janssen-Cilag Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the real-world characteristics and outcomes of participants with smoldering multiple myeloma (SMM) overall and by high-risk and non-high-risk SMM according to (AQUILA study criteria \[NCT03301220\], Mayo 20-2-20 and international myeloma working group (IMWG) 2020 risk classification models), and to evaluate the risk of progressing of SMM to multiple myeloma (MM) and outcomes in participants after progressing to MM.
Conditions
Timeline
- Start date
- 2024-05-31
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-06-25
- Last updated
- 2026-04-13
Locations
29 sites across 5 countries: France, Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT06472778. Inclusion in this directory is not an endorsement.